69th Day Of Lockdown

Maharashtra65168280812197 Tamil Nadu2024611313157 Delhi173877846398 Gujarat1635692321007 Rajasthan83654855184 Madhya Pradesh78914444343 Uttar Pradesh77014651213 West Bengal48131775302 Andhra Pradesh3461228960 Bihar3359120915 Karnataka292299749 Telangana2499141277 Jammu and Kashmir234190828 Punjab2197194942 Odisha17239779 Haryana172194019 Kerala120957510 Assam9361044 Uttarakhand493794 Jharkhand4621914 Chhatisgarh4471021 Chandigarh2891994 Tripura2711720 Himachal Pradesh223634 Goa70420 Manipur6060 Puducherry57230 Nagaland3600 Meghalaya27121 Arunachal Pradesh310 Mizoram110 Sikkim100
Business Other News 05 Jun 2019 Pharmas face pricing ...

Pharmas face pricing pressure: Dr Reddy's Lab

DECCAN CHRONICLE.
Published Jun 5, 2019, 1:18 am IST
Updated Jun 5, 2019, 1:18 am IST
We expect this trend of increased pricing pressures to continue.
In a regulatory filing, the pharma major said its top 10 customers in the US account for about 77 per cent of its revenues from the North America Global Generics. “Consolidation and integration of the drug wholesalers, retail drug chains, private insurers, managed care organisations and other purchasing organisations may continue to adversely affect pharmaceutical manufacturers.
 In a regulatory filing, the pharma major said its top 10 customers in the US account for about 77 per cent of its revenues from the North America Global Generics. “Consolidation and integration of the drug wholesalers, retail drug chains, private insurers, managed care organisations and other purchasing organisations may continue to adversely affect pharmaceutical manufacturers.

Hyderabad: With the drug selling channels in the US set to consolidate furthe, city-based pharma major Dr Reddy’s expect pricing pressure to remain for pharma firms.

In a regulatory filing, the pharma major said its top 10 customers in the US account for about 77 per cent of its revenues from the North America Global Generics. “Consolidation and integration of the drug wholesalers, retail drug chains, private insurers, managed care organisations and other purchasing organisations may continue to adversely affect pharmaceutical manufacturers.

 

“Such consolidations have resulted in these groups gaining additional purchasing leverage and, consequently, increasing the product pricing pressures facing our business.

“We expect this trend of increased pricing pressures to continue. Such pressures have reduced, and could continue to reduce, our revenue, margins and profitability,” the firm said.

In the US, similar to other pharmaceutical firms, Dr Reddy’s sells its products through wholesale distributors and large retail chains in addition to hospitals, pharmacies and other groups. Additionally, the emergence of large buying groups representing retail pharmacies, and the prevalence and influence of managed care organisations and similar institutions, creates competition among pharma firms to have their products included in the formulary of them.

...
Location: India, Telangana, Hyderabad




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT